Prolonged airway retention of Insoluble particles in cystic fibrosis versus primary ciliary dyskinesia

Experimental Lung Research

Volumn 26, Issue 3, 2000, Pages 149-162

  Regnis, Jeff A ^a   Zeman, Kirby L ^a   Noone, Peadar G ^a   Knowles, Michael R ^a   Bennett, William D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Mucociliary clearance; Primary ciliary dyskinesia

Indexed keywords

TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; AIRWAY DYNAMICS; ARTICLE; CILIARY DYSKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MALE; MUCOCILIARY CLEARANCE; PRIORITY JOURNAL; SCHOOL CHILD; SCINTILLATION CAMERA;

EID: 0034058903     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021400269844     Document Type: Article

References (30)

1. 1. Wanner A, Salathe M, O'Riordan TG: Mucociliary clearance in the airways (state of the art). Am J Respir Crit Care Med. 1996;154:1868-1902.
2. 2. Quinton PM: Cystic fibrosis: a disease in electrolyte transport. FASEB J. 1990;4:2709-2717.
3. 3. Regnis JA, Robinson M, Bailey DL, Cook P, Hooper P, Chan HK, Gonda I, Bautovich G, Bye PTP: Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med. 1994;150:66-71.
4. 4. Davis PB: Pathophysiology of the lung disease in cystic fibrosis. In: Davis PB, ed. Cystic Fibrosis. Lung Biology in Health and Disease. Vol. 64. New York: Marcel Dekker; 1993:193-218.
5. 5. Mossberg B, Afzelius BA, Eliasson R, Camner P: On the pathogenesis of obstructive lung disease: a study on the immotile-cilia syndrome. Scand J Respir Dis. 1978;59:55-65.
6. 6. Kollberg H, Mossberg B, Afzelius BA, Philipson K, Camner P: Cystic fibrosis compared with immotile-cilia syndrome. Scand J Resp Dis. 1978;59:297-306.
7. 7. Svartengren K, Philipson K, Svartengren M, Nerbrink O, Camner P: Clearance in smaller airways of inhaled 6 micron particles in subjects with immotile cilia syndrome. Exp Lung Res. 1995;21:667-682.
8. 8. Lippman M, Albert RE: The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J. 1969;30:257-275.
9. 9. Dolovich MB, Sanchis J, Rossman C, Newhouse MT: Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Applied Physiol. 1976;40:468-471.
10. 10. Camner P, Philipson K: Human alveolar deposition of 4-μm Teflon particles. Arch Environ Health. 1978;36:181-185.
11. 11. Stahlhofen W, Gebhart J, Rudolf G, Scheuch G: Measurement of lung clearance with pulses of radioactively labelled particles. J Aerosol Sci. 1986;17:333-338.
12. 12. Wolff RK, Tillquist H, Muggenburg BA, Harkema JR, Mauderly JL: Deposition and clearance of radiolabelled particles from small ciliated airways in beagle dogs. J Aerosol Med. 1989;2:261-270.
13. 13. Bennett WD, Scheuch G, Zeman KL, Brown JS, Kim C, Heyder J, Stahlhofen W: Bronchial airway deposition and retention of particles in inhaled boli: effect of anatomic dead space. J Appl Physiol. 1998;85:685-694.
14. 14. Anderson M, Philipson K, Svartengren M, Camner P: Human deposition and clearance of 6 μn particles inhaled with an extremely low flow rate. Exp Lung Res. 1995;21:187-195.
15. 15. Smaldone GC, Perry RJ, Bennett WD, Messina MS, Zwang J, Ilowite J: Interpretation of "24 hour lung retention" in studies of mucociliary clearance. J Aerosol Med. 1988;1:11-20.
16. 16. Ilowite JS, Smaldone GC, Perry RJ, Bennett WD, Foster WM: Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch Environ Health. 1989;44:267-273.
17. 17. Carson JL, Collier AM: Ciliary defects: cell biology and clinical perspectives. Adv Pediatr. 1998; 35:139-166.
18. 18. American Thoracic Society: Standardization of Spirometry - 1987 Update. Am Rev Respir Dis. 1987;136:1285-1298.
19. 19. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B: Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725-734.
20. 20. May KR: An improved spinning top homogenous spray apparatus. J Appl Physiol. 1949;20:932-938.
21. 99m-Tc-labelled iron oxide aerosols for human lung deposition and clearance studies. Int J Appl Radiat Isotopes. 1980;31:689-694.
22. 22. Ilowite JS, Gorvoy JD, Smaldone GC: Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis. 1987;136:1445-1449.
23. 23. Bennett WD, Olivier KN, Zeman KL, Hohnecker KW, Boucher RC, Knowles MR: Effect of Uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Grit Care Med. 1996;153:1796-1801.
24. 24. Chandra R: Introductory Physics of Nuclear Medicine. Philadelphia: Lea and Febiger; 1987:38-43.
25. 25. Pavia D, Thomson ML, Clarke SW, Shannon HS: Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977;32:194-197.
26. 26. Rossman CM, Forrest JB, Ruffin RE, Newhouse MT: Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am Rev Respir Dis. 1980;121:1011-1016.
27. 27. Camner P, Mossberg B, Afzelius BA: Measurements of tracheobronchial clearance in patients with immotile-cilia syndrome and its value in differential diagnosis. Eur J Respir. 1983;64(Suppl 127):57-63.
28. 28. Ruusa J, Svartengren M, Philipson K, Camner P: Tracheobronchial particle deposition and clearance in Immotile Cilia Syndrome Patients. J Aerosol Med. 1993;6:89-98.
29. 29. Scherer PW: Mucus transport by cough. Chest. 1981;80(Suppl 6)830-833.
30. 30. Girod S, Galabert C, Lecuire A, Zahm JM, Puchelle E: Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases. Pediatr Pulmon. 1992;13:22-27.